Skip to search.
 TSX Up 0.12% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Cytori Therapeutics, Inc. (CYTX)

-NasdaqGM
2.55 Down 0.06(2.30%) 12:37PM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:2.61
Open:2.61
Bid:2.53 x 700
Ask:2.54 x 1500
1y Target Est:8.25
Beta:2.32
Next Earnings Date:N/A
Day's Range:2.46 - 2.61
52wk Range:2.00 - 3.93
Volume:147,023
Avg Vol (3m):544,698
Market Cap:192.39M
P/E (ttm):N/A
EPS (ttm):-0.39
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Must Read

Comparison

Symbol% ChgMkt Cap
CYTXDown 2.30%192.39M
ASTMUp 0.02%26.85M
BAXDown 0.12%39.27B
OSIRDown 0.46%447.95M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.15
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.43
Quarterly EPS Est (Mar-14) :-0.14
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cytori Therapeutics, Inc., a cell therapy company, develops cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and other medical conditions. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback